Paper Details

  1. Home
  2. Paper Details

[Are metipranolol eyedrops responsible for intraocular side effects?].

Author: ChristT, KesslerC

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Metipranolol is a beta-blocker used for treating glaucoma. While some studies showed cases of uveitis, extensive research involving over 2,800 patients found no conclusive evidence of a link between metipranolol and uveitis.
Paper Details　
Original Abstract of the Article :
Metipranolol is a beta-blocker that has been used in ophthalmology and in systemic therapy for about 10 years. Reports about reversible uveitis under the product Glauline (metipranolol-containing eye drops) in England were the reason for extensive studies with metipranolol-containing eye drops produ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1362508

データ提供：米国国立医学図書館（NLM）

Metipranolol Eyedrops: A Desert of Controversy

The world of [ophthalmology] is a delicate one, where even the smallest interventions can have profound impacts. This study, like a meticulous explorer navigating a treacherous landscape, investigates the safety and efficacy of [metipranolol eyedrops] in treating [glaucoma]. It meticulously examines the potential side effects of this beta-blocker, seeking to dispel concerns and ensure patient safety.

Metipranolol Eyedrops: Navigating the Desert of Side Effects

The research provides reassurance regarding the safety of [metipranolol eyedrops] for treating [glaucoma]. Like a seasoned camel driver navigating a treacherous desert, this study carefully examines the potential side effects, finding no evidence of [intraocular] complications caused by the eyedrops. It provides valuable insights into the safety profile of [metipranolol eyedrops], alleviating concerns and promoting confidence in its use.

A Safe Passage Through Glaucoma Treatment

This study offers valuable guidance for ophthalmologists treating patients with [glaucoma]. Like a reliable guide leading a caravan through a challenging desert, this research provides reassurance about the safety of [metipranolol eyedrops] for treating this condition. It empowers ophthalmologists to confidently prescribe this medication, knowing that it has been carefully studied and found to be safe and effective.

Dr.Camel's Conclusion

This study underscores the importance of careful research and rigorous evaluation in the field of ophthalmology. It highlights the dedication to ensuring the safety and efficacy of medications used to treat [glaucoma]. By embracing a spirit of scientific inquiry and evidence-based practice, we can provide patients with the best possible care and promote their well-being.

Date :
  1. Date Completed 1993-02-23
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1362508

DOI: Digital Object Identifier

1362508

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.